Our scientific advisory board is comprised of the following:
Dennis Ausiello, MD |
Physician-in-Chief, Massachusetts General Hospital; Director, Pfizer Inc |
Michael Brownstein, MD PhD |
Senior Consultant, Chemical & Biological Security Program Lawrence Livermore National Laboratory Director, Functional Genomics, J. Craig Venter Institute Chief, Genetics Laboratory, NIMH/NHGRI |
Jeffrey Gelfand, MD |
Clinical Professor of Medicine, Harvard Medical School;Chairman Clinician, Infectious Disease and Immunology, Massachusetts General Hospital |
Vsevolod Kiselev, MD |
Professor of Medicine, Moscow Medical Academy |
Arthur Krieg, PhD |
VP, Pfizer Biotherapeutics and Bioinnovation Center; Founder and CSO, Coley Pharmaceuticals |
Adel Mahmoud, MD |
Former President, Merck Vaccines |
Joseph Martin, MD |
Former Dean, Harvard Medical School |
John Parrish, MD |
Executive Director and Founder, CIMIT |
George Poste, PhD |
Director, Arizona Biodesign Institute; Former CSO, SmithKline Beecham |
Patrick Scannon, PhD |
Founder and CSO, Xoma Corporation |